N. Barbet

Improved Sphincter Preservation in Low Rectal Cancer With High-Dose Preoperative Radiotherapy: The Lyon R96-02 Randomized Trial

Jean-Pierre Gérard, O. Chapet, Chantal Némoz et al. · Journal of Clinical Oncology · 2004 · 317 citations

Preoperative Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer With High-Dose Radiation and Oxaliplatin-Containing Regimen: The Lyon R0–04 Phase II Trial

J.P. Gérard, O. Chapet, Chantal Némoz et al. · Journal of Clinical Oncology · 2003 · 207 citations

Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial

Jean‐Pierre Gérard, N. Barbet, Renaud Schiappa et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 156 citations

Radiation Medicine, Surgical Oncology, Neoadjuvant Chemoradiotherapy +9

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6

Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study

Jean‐Pierre Gérard, N. Barbet, Jocelyn Gal et al. · European Journal of Cancer · 2018 · 85 citations

Transplantation Surgery, Surgical Oncology, Colorectal Surgery +8